Preclinical development of a next generation antibody drug conjugate (ADC) targeting B7-H3 for treatment of solid tumors

被引：1
|
作者：
Xu, Jian
Zong, Qing
Wang, Wei
Liu, Qigang
Stann, Sasha
Cai, Jiaqiang
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-6304
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6304
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Generation and preclinical characterization of CD123-CPI antibody-drug conjugate (ADC)
    Han, Yoon-Chi
    Jiang, Fan
    Piche-Nicholas, Nicole
    Katragadda, Madan
    Prashad, Nadira
    Charati, Manoj
    Hu, Wendy
    Leal, Mauricio
    Tumey, Nathan
    Maderna, Andreas
    Dushin, Russell
    Kim, Kenny
    Lemon, LuAnna
    Damelin, Marc
    Gerber, H. P.
    Tchistiakova, Lioudmila
    Loganza, Frank
    O'Donnell, Chris
    Sapra, Puja
    CANCER RESEARCH, 2018, 78 (13)
  • [42] YL201, a novel B7H3-targeting antibody-drug conjugate (ADC), in patients (pts) with advanced solid tumors: Results from a first-in-human phase I study
    Zhao, H.
    Ma, Y.
    Meng, X.
    Wu, L.
    Fan, Y.
    Zheng, Y.
    Liu, Z.
    Ji, Y.
    Lv, D.
    Luo, S.
    Sommerhalder, D.
    Fu, S.
    Huang, Y.
    Yang, Y.
    Fang, W.
    Zhao, Y.
    Wang, Y.
    Chin, S.
    Xue, T.
    Zhang, L.
    ANNALS OF ONCOLOGY, 2024, 35 : S485 - S485
  • [43] Tandem CAR-T cells targeting CD70 and B7-H3 exhibit potent preclinical activity against multiple solid tumors
    Yang, Meijia
    Tang, Xin
    Zhang, Zongliang
    Gu, Lei
    Wei, Heng
    Zhao, Shasha
    Zhong, Kunhong
    Mu, Min
    Huang, Cheng
    Jiang, Caiying
    Xu, Jianguo
    Guo, Gang
    Zhou, Liangxue
    Tong, Aiping
    THERANOSTICS, 2020, 10 (17): : 7622 - 7634
  • [44] Phase 1 dose escalation study of MGC018, an anti-B7-H3 antibody-drug conjugate (ADC), in patients with advanced solid tumors.
    Jang, Sekwon
    Powderly, John D.
    Spira, Alexander I.
    Bakkacha, Ouiam
    Loo, Deryk
    Bohac, Gerry C.
    Sharma, Manish
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [45] MGC018, an anti-B7-H3 antibody-drug conjugate (ADC), in patients with advanced solid tumors: Preliminary results of phase I cohort expansion
    Shenderov, E.
    Mallesara, G. H. G.
    Wysocki, P. J.
    Xu, W.
    Ramlau, R.
    Weickhardt, A. J.
    Zolnierek, J.
    Spira, A.
    Joshua, A. M.
    Powderly, J.
    Antonarakis, E. S.
    Jang, S.
    Aragon-Ching, J.
    Shen, J.
    Paller, C.
    Vogelzang, N. J.
    Leu, K.
    Cortes, J.
    Bohac, C.
    Lugowska, I.
    ANNALS OF ONCOLOGY, 2021, 32 : S657 - U246
  • [46] Developing a next generation antibody drug conjugate for treatment of gastrointestinal cancers
    Mysliwy, Justyna H.
    Lodge, Adam
    Williamson, Daniel
    Thirlway, Jenny
    Deckert, Jutta
    Lutz, Robert J.
    CANCER RESEARCH, 2022, 82 (12)
  • [47] Development of a Specifically Labeled 89Zr Antibody for the Noninvasive Imaging of Tumors Overexpressing B7-H3
    Zheng, Meng
    Liu, Qingfeng
    Zhang, Hua
    Wang, Yanan
    Zhang, Kaijie
    Mu, Huiwen
    Fu, Fengqing
    Zhang, Xueguang
    Wang, Yan
    Miao, Liyan
    MOLECULAR PHARMACEUTICS, 2024, 21 (10) : 5205 - 5216
  • [48] The B7-H3-Targeting Antibody-Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models
    Kendsersky, Nathan M.
    Lindsay, Jarrett
    Kolb, E. Anders
    Smith, Malcolm A.
    Teicher, Beverly A.
    Erickson, Stephen W.
    Earley, Eric J.
    Mosse, Yael P.
    Martinez, Daniel
    Pogoriler, Jennifer
    Krytska, Kateryna
    Patel, Khushbu
    Groff, David
    Tsang, Matthew
    Ghilu, Samson
    Wang, Yifei
    Seaman, Steven
    Feng, Yang
    St Croix, Brad
    Gorlick, Richard
    Kurmasheva, Raushan
    Houghton, Peter J.
    Maris, John M.
    CLINICAL CANCER RESEARCH, 2021, 27 (10) : 2938 - 2946
  • [49] First-in-human study of the B7-H4 antibody-drug conjugate (ADC) AZD8205 in patients with advanced/metastatic solid tumors
    Meric-Bernstam, Funda
    Oh, Do-Youn
    Naito, Yoichi
    Shimizu, Toshio
    Chung, Vincent
    Park, Haeseong
    Gaillard, Stephanie
    Wang, Fujun
    Cooper, Zachary A.
    Kinneer, Krista
    Rebelatto, Marlon
    Kirby, Lyndon
    Luheshi, Nadia
    Miller, Neil
    Varga, Andreea
    Mileshkin, Linda R.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [50] Developing a novel doppel-targeting antibody-drug conjugate (ADC) for solid cancer
    Lee, Ha Kyeong
    Kim, Byoungmo
    Kweon, Seho
    Choi, Jeong Uk
    Kim, Sang Yoon
    Byun, Youngro
    CANCER RESEARCH, 2023, 83 (07)
12345